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0022-2836 © 2012 Elsevier Ltd. Open accThe amyloid precursor protein (APP) and its neurotoxic cleavage product
Aβ are key players in the development of Alzheimer's disease and appear
essential for neuronal development and cell homeostasis in mammals.
Proteolytic processing of APP is influenced by metal ions, protein ligands
and its oligomerization state. However, the structural basis and functional
mechanism of APP regulation are hitherto largely unknown. Here we
identified ametal-dependentmolecular switch locatedwithin the E2 domain
of APP containing four evolutionary highly conserved histidine residues.
Three X-ray structures of the metal-boundmolecule were solved at 2.6–2.0 Å
resolution. Using protein crystallographic and biochemical methods, we
characterized this novel high-affinity binding site within the E2 domain that
binds competitively to copper and zinc at physiological concentrations.
Metal-specific coordination spheres induce large conformational changes
and enforce distinct structural states, most likely regulating the physiolog-
ical function of APP and its processing in Alzheimer's disease.
© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Deposition of the characteristic senile plaques and
neurofibrillary tangles within the brain is a diag-
nostic hallmark of Alzheimer's disease (AD). Senile
plaques accumulate by aggregation of neurotoxic
Aβ peptide species derived from the amyloid
precursor protein (APP) by sequential proteolysisress:
d precursor protein;
per binding domain;
rotein Data Bank;
ITC, isothermal
asmon resonance; RU,
ess under CC BY-NC-ND licenby β- and γ-secretases. Imbalanced processing or
clearance of APP is generally believed to result in
AD pathology (reviewed in Refs. 1–3). Interestingly,
in AD patients and in APP transgenic mice, the
homeostasis of the divalent transition metals copper
and zinc is imbalanced. Manipulations of intracel-
lular copper can influence the regulated intramem-
brane proteolysis of APP as well as the production
of Aβ. This implicates a role of APP in metal
metabolism and led to the suggestion of metal
chelation therapy as a possible anti-AD treatment.4–6
Efforts to address the physiological function of
APP and its dysfunction in AD are mainly compli-
cated by the multiple domain architecture of the
extracellular portion providing multiple functional-
ities, as well as the largely unknown functional
differences and redundancies among the distinct
APP family members and their tissue-specificse.
439Conformation and Function of the APP-E2 Domainsplicing forms (reviewed in Ref. 7). The ectodomain
of all APP family members comprises two subdo-
mains of high sequence conservation, the E1 and the
E2 domains. Two tightly interacting subdomains
constitute the E1 domain,8 called growth factor-like
domain and copper binding domain (CuBD). E1 and
E2 are connected by a potentially flexible, less well
conserved linker region of unknown function,
primarily composed of acidic amino acids (AcD).
A second linker of undefined structure, containing
the cleavage sites of α- and β-secretases, anchors the
whole extracellular part to the single transmembrane
helix. Some APP and APLP2 isoforms feature an
additional Kunitz-type protease inhibitor domain
located between the AcD and E2 (reviewed in Ref. 9).
The E1 domain and especially its heparin binding
loop mediate homophilic interactions of APP,10–12
consistent with the heparin-induced dimerization
as observed for the isolated E1 domain8 as well
as for sAPPα.13 The contribution of the E2 domain
to the oligomerization of APP is controversially
discussed10,14–17 and might differ between the
family members APLP118 and APP.15
In particular, little is known about possible
conformational changes in the E2 domain that may
influence its biochemical properties and hence the
function of APP in the cellular context. The fold of the
E2 domain is highly flexible, indicated by large
conformational differences between the available E2
structures. As a result, partially disordered crystals,19
anisotropic crystals and high overall B-factors of the
structures14,16,20 complicated previous X-ray crystal-
lographic studies. In agreement, an NMR study and
proteolytic studies showed that only a part of the E2
domain is rigidly folded in solution.21
Whether metal-ion-mediated effects in APP phys-
iology relate to metal homeostasis defects in AD
pathology is controversially discussed. Originally,
the binding sites of copper and zinc ions were
identified close to the C-terminus of the APP-E1
domain by peptide mapping.22,23 Later, His147,
His151 and Tyr168 were identified as copper
coordination sphere of the CuBD.24 However, the
Cu2+ binding site is partially obstructed by the
tightly associated growth factor-like domain.8 Bind-
ing of copper to crystals of the isolated CuBD was
only observed at high concentrations and in one of
the two investigated crystal forms.24 Considering
the low dissociation constant of the full-length
protein,22 an additional yet unknown high-affinity
copper binding site in APP can be expected.
Similarly, the zinc binding peptide, mapped to
amino acids 181–200, showed weaker binding than
full-length APP, and potentially distinct coordina-
tion sites in APP were discussed.23
In order to gain a complete understanding of the
structure of the E2 domain that gives rise to its
physiologic function, its influence on the entire
protein and the development of AD, we analyzedthe biochemical properties of this domain especially
with respect to its metal binding properties and
solved the crystal structure in the presence of
different metal ions. We identified a so far unknown
competitive metal binding site within the structure
of the E2 domain and show a metal-dependent
conformational switch regulating the conformation,
flexibility and hence the physiological function of
APP-E2 and full-length APP.Results
High-resolution X-ray structure of the human
APP-E2 domain
We identified a new tetragonal crystal form with
improved diffraction properties that grew from
cadmium-containing crystallization buffer. Using a
partial molecular replacement (MR) solution with
the Caenorhabditis elegans APL-1 E2 structure [Protein
Data Bank (PDB) ID: 3K6620] as search model, we
identified protein-bound cadmium atoms from
anomalous difference Fourier maps. Final phases
were calculated by single anomalous dispersion
(SAD), resulting in a well-defined experimental
electron density map. The structure was build and
refined to 2.0 Å resolution, showing good R-factors
and stereochemistry (Table 1). Exclusively composed
of α-helical secondary structure, the molecule adopts
an elongated shape spanning ∼95 Å×35 Å× 25 Å
(Fig. 1a). The short N-terminal helix α-A14 was not
observed in our tetragonal crystal form. The fold of
the E2 domain is dominated by the central ∼ 90-Å-
long helix α-C, which is in contact to all other helices.
Helix α-B (His313–Gln344) and the first 36 amino
acids of the central helix α-C (Lys350–Arg385)
contribute to a coiled-coil like fold. The C-terminal
part of helix α-C (Val386–Gln406) together with
helices α D (Arg411–Asp444), α-E (Lys446–Tyr474)
and α-F (Val479–Gln492) constitutes a four-helix
bundle enclosing a small hydrophobic core. The
strict heptad repeat pattern is distorted in the E2
N-terminal coiled-coil like region as noted before.14
Analysis of the contact surfaces of those helices
revealed a similar solvation free-energy gain (ΔiG)
for different E2 structures (Table 2). Hence,
different relative orientations of these helices result
in similar hydrophobic inter-helix contacts, explain-
ing the high flexibility observed in previous
structural studies of the human E2 domain.14,16,21
Conserved intramolecular copper/zinc binding
site in APP-E2
Interestingly, cadmium ions present in the crys-
tallization buffer bound at various intermolecular
(Cd3, Cd4, Cd5, Cd6 and Cd8) and intramolecular
Table 1. Data collection and refinement statistics
Data set
Cd2+ lowE Cd2+ Zn2+ Peak Zn2+ lowE Cu2+ Peak Cu2+ lowE
Data collection statistics
Wavelength (Å) 1.600 0.918 1.282 1.284 1.378 1.382
Resolution limit (Å) 2.7 2.0 2.4 2.5 2.6 2.7
Unit cell parameters P43
a (Å) 39.3 39.7 39.7 39.8
c (Å) 125.9 126.2 125.8 126.5
Completeness (%)a 100.0 (100.0) 100.0 (100.0) 98.3 (89.0) 99.7 (98.4) 98.2 (88.3) 99.8 (99.4)
Rmerge (%)
a 9.1 (42.2) 5.6 (38.6) 2.9 (7.9) 3.4 (7.9) 3.4 (9.9) 3.6 (10.2)
〈I/σI〉
a 46.2 (8.7) 14.0 (3.4) 27.1 (12.1) 22.8 (13.2) 23.5 (10.0) 21.1 (10.1)
Redundancya 43.2 (33.8) 4.2 (4.1) 4.0 (3.2) 4.1 (4.0) 4.1 (3.5) 4.0 (3.8)
Refinement statistics
Structure Cd2+ Zn2+ Cu2+
Resolution (Å) 28.0–2.0 28.0–2.4 25.7–2.6
Unique reflectionsb 12,503/647 7020/433 5597/341
Rwork (%)/Rfree (%) 19.8/23.7 20.4/24.5 20.6/23.9
Nonhydrogen atoms
Protein 1509 1535 1543
Water 95 79 63
Metal ions 9 9 9
Acetate ions 8 4 4
B-factors (Å2)
Overall/Wilson plot 41.0/31.2 36.7/40.2 39.7/50.0
Protein 40.6 36.3 39.6
Water 47.5 44.8 43.0
Metal ions 40.5 40.7 44.6
Acetate ions 46.3 32.9 35.5
RMSDs
Bond lengths (Å) 0.0073 0.0049 0.0048
Bonded B-factors (Å2) 3.6 3.1 2.6
a Values given in parenthesis represent the highest-resolution shell. (Data collection: Cd2+ lowE, 2.85–2.70 Å; Cd2+, 2.11–2.00 Å;
Zn2+ peak, 2.53–2.40 Å; Zn2+ lowE, 2.64–2.50 Å; Cu2+ peak, 2.74–2.60 Å; Cu2+ lowE, 2.85–2.70 Å; Refinement: Cd2+, 2.09–2.00 Å;
Zn2+, 2.40–2.51 Å; Cu2+, 2.60–2.72 Å.)
b Work/free.
440 Conformation and Function of the APP-E2 Domainsites (Cd1, Cd2, Cd7 and Cd9) (Fig. 1a). Most
interestingly, the cadmium ion Cd1 at metal binding
site M1 is surrounded by four histidine side chains
(His313, His382, His432 and His436) (Fig. 1b; for
stereo view, see Fig. S1a) of helices α-B, α-C and α-D
in multiple coordination geometries. Similarly,
helices α-C, α-D and α-E contribute to multiple
binding states of Cd2 by Glu387, Asp429, His458
and a defined water molecule at metal binding site
M2 (Fig. 1b; for stereo view, see Fig. S2a). Cd7 and
Cd9 are bound by one amino acid side chain only,
corresponding to weak binding sites that show a
low occupancy in the structure. In consequence,
both the E2 molecule and the crystal lattice are
stabilized by a large number of defined cadmium
ions, resulting in reduced flexibility of the molecule
and high diffraction power of this crystal form.
The metal binding sites M1 and M2 provide
coordination spheres suited for intramolecular
binding of physiological transition metal ions such
as copper and zinc. To probe the competitive
displacement of Cd2+, we soaked the crystals in a
solution supplemented with either Cu2+ or Zn2+ inaddition to Cd2+. Two complete data sets were
collected in the vicinity of the K absorption edge for
each of the two elements (Table 1) in order to
calculate element-specific anomalous double differ-
ence electron density maps25 (Fig. 1c and d; for
stereo view, see Fig. S1b and c and Fig. S2b and c).
Zn2+ specifically replaces exceeding cadmium
ions at binding site M1 and is coordinated by three
histidines (His382, His432 and His436) as well as
one water molecule in an almost tetrahedral
geometry (Fig. 1c; for stereo view, see Fig. S1b).
Upon specific replacement of Cd2+ by Cu2+, the
electron density of His313 becomes well defined,
and four histidines form a coordination sphere best
described as tetrahedrally distorted square planar
geometry (Fig. 1d; for stereo view, Fig. S1c). At
metal binding site M2, the bound cadmium ion Cd2
was only partially replaced by Zn2+ and not affected
by Cu2+ in the soaked crystals (Fig. 1c and d; for
stereo view, see Fig. S2b and c). This observation
indicates high specificity of M1 for Zn2+ and Cu2+
but low specificity of site M2 for these metal ions.
The conservation analysis of both internal metal
Fig. 1. Structure of the APP-E2 domain. (a) Cartoon representation of the APP-E2 domain with intramolecular
(dark-gray spheres) and intermolecular (light-gray spheres) bound cadmium ions. The color gradient from blue to red
indicates progression of the protein chain from the N- to the C-terminus. Amino acid side chains involved in metal
coordination are shown as sticks. Crystallographic symmetry mates of cadmium ions were included in the picture to
visualize the crystal contacts mediated by cadmium. The rectangles highlight the two intramolecular metal binding
sites (M1 and M2), characterized by a complex coordination sphere. (b–d) Intramolecular metal binding sites M1
and M2. The electron density of the composite annealed 2Fo−Fc omit map contoured at 0.9 σ is shown in blue.
(b) Cadmium occupied state: Both binding sites show multiple conformations of coordinating residues and cadmium
ions. Cadmium ions are represented by spheres colored dark gray. (c) In ZnCl2-soaked crystals, cadmium is replaced
completely by zinc at site M1 and partially at site M2, indicated by the zinc-specific anomalous double difference density
map contoured at 7 σ (magenta). (d) In CuCl2-soaked crystals, cadmium is completely replaced by copper at site M1 but
not at site M2, indicated by the copper-specific anomalous double difference density contoured at 7 σ (cyan). (b and c)
The anomalous difference map at low energy, representing bound cadmium, is contoured at 5 σ (yellow).
441Conformation and Function of the APP-E2 Domainbinding sites is in excellent agreement with this
observation. Alignments of APP, APLP1 and APLP2
sequences show that His313, His382, His432 and
His436 at site M1 are highly conserved within the
APP superfamily, including APLP1 and APLP2
(Fig. 2). In contrast, a similar conservation pattern
of the amino acids at site M2 was not observed.Table 2. Interaction within the N-terminal coiled-coil of differ
Molecule/structure
Residues in
helix α-B
APP Cu2+ bounda 313–347
APP metal free (PDB ID 1RW6)b 369–403
APL-1 metal free (PDB ID 3K66)c 248–282
a Numbering according to APP isoform APP695.
b Numbering according to APP isoform APP751.
c C. elegans APL-1.Binding of copper/zinc in solution
The ability of the E2 domain to bind copper and
zinc in solution was confirmed in an ultrafiltration-
based retention assay (Fig. 3a). Both copper and zinc
ions accumulated in the retenate of the ultrafiltration
device upon APP-E2 concentration, but not in theent E2 structures
Residues in
helix α-C
Interaction
interface (Å2)
Free-energy of
interaction
ΔiG (kcal/mol)
350–388 816 −13.7
406–444 771 −18.5
292–330 754 −17.2
Fig. 2. Conservation analysis. Structure-based sequence alignments of vertebrate and invertebrate APP homologues
and human APP-like proteins. Sequence similarities are highlighted in gray, and identical amino acids are shown in
white on a black background. The ideogram on top of the alignment indicates α helical regions in the structure. The
color gradient maps the sequence to the cartoon representation of the structure shown in Fig. 1a. Amino acids
involved in the binding of cadmium ions are designated by numbers corresponding to the respective Cd2+ binding
site below the alignment. The highly conserved histidines involved in binding of copper and zinc at site M1 are
highlighted in magenta.
442 Conformation and Function of the APP-E2 Domaincontrols. Several of the intermolecular metal binding
sites can at least be partially occupied by copper or
zinc ions (Fig. S3). To avoid these intermolecular
contacts and hence precipitation of the E2 domain in
solution, we always used 50 mM Tris as buffer to
complex Cu2+.
Determination of the binding strength by iso-
thermal titration calorimetry (ITC) revealed tight
binding of copper to the E2 domain (Fig. 3b),
characterized by an apparent dissociation constant
Kdapp of 610 nM (Table 3), which has to be corrected,
however, for the competition by the ligand Tris and
its pH-dependent protonation.26 The exact coordi-
nation chemistry of Cu2+ by Tris is, unfortunately,
not precisely known; for example, tertiary Cu(Tris)2
and quinary Cu(Tris)4 complexes are described in
the literature. However, all models agree about the
initial formation of a binary Tris–Cu2+ complex,described by a formation constant pK1(Tris) of ∼4.
Considering only this first complexation step for
correcting the apparent Kdapp, a binding constant Kd
of 13 nM was calculated as upper (weakest) limit. A
similar calculation assuming the quinary Cu(Tris)4
complex26 results in values as low as 2 pM. In
addition, we determined the apparent Kdapp as
function of the Tris concentration showing a linear
dependency (Fig. 3c). This was initially surprising,
as we expected a higher-order relationship due to
the stoichiometry of described (Tris)n–Cu
2+ com-
plexes. Based on the linear dependency, we con-
cluded that the higher-order association steps [i.e.,
Cu(Tris)n→Cu(Tris)n+1] are of less influence on the
effective copper concentration under the used
conditions and that our correction with pK1(Tris) is
quite adequate. The used concentrations of Tris were
chosen such that it was always in large excess (N100-
Fig. 3. Binding of zinc and copper to APP-E2 in solution. (a) Metal retention assay probing the capability of the protein to
retain metal ions upon concentration. The ratio of the metal concentration in the retenate relative to the initial metal
concentration is shown after 8-fold concentration by centrifugation in the presence of the E2 domain and of a control protein
(lysozyme) and in the absence of any protein (blank). (b) ITC binding curve of copper to APP-E2. (c) Dependence ofKdapp on
Tris concentration. Kdapp of copper to APP-E2 was measured at 15 mM, 25 mM, 50 mM and 75 mM Tris in ITC experiments.
Kdapp was plotted as a function of [Tris], linearly fitted and evaluated assuming competition of APP-E2 with Cu(Tris)
according to Kdapp=Kd+K1Tris×Kd×[Tris]. (d) ITC binding curve of zinc to APP-E2. Filled triangles represent integrals for a
zinc titration experiment with copper-pre-saturated APP-E2. The exothermic binding reaction observed for binding of zinc
to APP-E2 is completely suppressed if copper is bound to the protein. (e) ITC measurements at high Zn/protein ratios. The
ITC peak integrals of the first and third titration runs of a serial titration experiment to achieve zinc saturation are shown as
squares. Filled squares represent reliable data points, whereas open squares mark data points adversely affected by dilution
due to the refilling procedure necessary after each titration run. (f) Experimental determination of the average number of
zinc ions bound to APP-E2. Initial precipitation by excess zinc followed by several wash steps resulted in a stable
equilibrium ratio of zinc-bound protein in the liquid phase and in the solid phase. Concentrations of zinc and protein and
the ratio between zinc and protein are shown for seven subsequent wash steps, when the equilibriumwas reached. The final
ratio is 4.3 total (corresponding to one tight and 3.3 weak) zinc binding sites per E2 molecule.
443Conformation and Function of the APP-E2 Domainfold) over Cu2+ in order to suppress the occupation
of weaker Cu2+ binding sites. In all ITC experi-
ments, the binding isotherms showed a single
inflection point and were indicative of one set ofidentical binding sites with stoichiometries of ∼1
(Fig. 3b and data not shown). Correspondingly, a
linear extrapolation results in a Kd of ∼20 nM as
intersection point with the ordinate in good
Table 3. Binding constants of Cu2+ and Zn2+ to APP-E2
determined by ITC
Cu–APP-E2
Zn–APP-E2Kdapp Kd
Kd1 (μM) 0.61±0.23 0.013±0.005 3.9±1.5
Kd2 (mM) — 2.6±1.2
a
ΔH1 (kJ/mol) −19.9±0.9 −16.6±0.6
ΔH2 (kJ/mol) — 1200±600
n1 0.70±0.03 0.7±0.2
n2 — 3.3
b
a Not statistically significant in curve fit as confidence intervals
exceed the measured values at a confidence level of 99%.
b Determined independently and fixed during curve fit.
444 Conformation and Function of the APP-E2 Domainagreement with our correction model applying
pK1(Tris) (see also Materials and Methods).
To study the formation of the Zn2+–APP-E2
complex in ITC experiments, the addition of specific
zinc chelators to the Hepes buffer resulted in
apparent binding constants that were too low for
numeric evaluation. Therefore, we measured zincFig. 4. Metal ions induce conformational changes in APP-E
obtained from injections of zinc chloride and (c and d) copper
interactions, spectra were recorded in the presence of (b) 20 mM
were injected at a flow rate of 30 μl/min for (a, c and d) 300 s
metal–protein complex in running buffer.binding in the absence of a zinc-specific chelator and
evaluated the ITC data as arising from multiple zinc
binding sites including unspecific association of zinc
ions to the protein surface. The binding isotherm
showed an initial exothermic reaction correspond-
ing to one strong interaction followed by an
endothermic contribution apparently arising from
multiple weak binding sites (Fig. 3d). ITC experi-
ments at high zinc-to-protein ratios (Fig. 3e) showed
a continuous, smooth decline of the endothermic
reaction. No saturation of zinc binding could be
observed, and the protein begun to precipitate at
zinc-to-protein ratios exceeding 5:1. Hence, the total
number of zinc binding sites at APP-E2 was
determined experimentally (Fig. 3f) and used to
evaluate the binding curves employing a model of
two sets of independent binding sites. The resulting
dissociation constants Kd1 of 3.9 μM and Kd2 of
2.6 mM have to be regarded as upper (weakest) limit
since Kd2 is determined not statistically significant in
the fit (Table 3). A possibly lower Kd2 necessarily
results in a decreased Kd1 value. Higher values of
Kd2 however would affect Kd1 slightly but would2. (a and b) Overlays of representative SPR sensorgrams
chloride solutions. For suppression of weak metal–protein
citrate or (d) 20 mM Tris. Ions at indicated concentrations
or (b) 100 s, respectively, followed by dissociation of the
445Conformation and Function of the APP-E2 Domaincause an increase in ΔH2 to values even higher than
1200 kJ/mol, unlikely for non-covalent interactions.
To verify that zinc and copper compete for the
same binding site in solution, we repeated the zinc
binding experiments with APP-E2 preparations
pre-saturated with copper. If copper ions are bound
to the protein, the exothermic reaction upon Zn2+
addition is completely missing from the ITC profile,
as expected for a competitive metal binding site
(Fig. 3d). In contrast, the unspecific binding is still
observed as indicated by the continuous endother-
mic signal.
Metal binding causes large conformational
changes in APP-E2 in solution
Next, we evaluated binding of Cu2+ and Zn2+ to
APP-E2 by surface plasmon resonance (SPR) analy-
sis. Interestingly, the addition of Zn2+ (Fig. 4a and b)
and Cu2+ (Fig. 4c and d) to APP-E2 covalently
attached to the chip surface resulted in a large
increase in the SPR signal up to ∼130 response units
(RU). The rise in RU upon injection of metal ion
solutions is too high to be explained by binding of
single metal ions. Furthermore, the binding curves
exhibit complex functions that cannot be attributed
to a standard model of binding kinetics. This
indicates structural rearrangements of the protein
bound to the sensor chip surface. To analyze the
contribution of weaker metal ion binding sites to the
binding curves, we added specific chelators of Zn2+
(Citrat) and Cu2+ (Tris), which reduced the com-
plexity of the binding curves (Fig. 4b and d). This
indicates that the SPR signal increase can be partially
explained by multiple binding sites on the protein
and that the chelators compete with the weakerFig. 5. Conformational differences between metal-bound a
C-terminal parts of metal-bound APP-E2 (Arg385–Leu490, AP
APP751 numbering)
14 in cyan and brown, respectively. To mark
chains of the copper coordination sphere are shown as sticks,
(b) A hinge region in helix α-C causes a concerted, rigid-body r
12° in the metal-bound APP-E2 domain. (c) Fixation of helix α-
a twist of 7° in the N-terminal coiled-coil. (d) Detailed view of
and the structural rearrangements following metal binding. Tmetal binding sites. However, the unexpectedly high
SPR signal increase of ∼50 RU (Zn2+) and ∼150 RU
(Cu2+) still suggests major conformational rearran-
gements in the presence of the chelators.
Conformational differences between metal-bound
and metal-free structures of the E2 domain
A structural alignment of the C-terminal parts
(Ala388–Gln492) of the copper-bound (this work)
and the metal-free (PDB ID: 1RW614) human APP-
E2 structures revealed a specific reorientation of the
N-terminal segment (Fig. 5a). In the metal-free
protein, helix α-B and the N-terminal part of helix
α-C are highly flexible and can adopt multiple
conformations. Conformational dynamics of this
segment were confirmed in APL-120 and APLP1,16
underscoring a general mode of flexibility of the E2
domains in the APP superfamily. The functional
consequences of APP-E2's flexible nature were
unknown until now, but they are apparent in the
context of metal binding. Binding of ions such as
Cu2+ requires a specific coordination geometry and
hence a specific conformation of the APP-E2
domain. The N-terminal coiled-coil, consisting of
the N-terminal half of helix α-C and the preceding
helix α-B, is rotated as rigid body by 12° (angle of
α-carbon segments between Ala355 and Ala388)
(Fig. 5b). Rotation occurs at a hinge region between
His382 and Ala388. An additional movement twists
helices α-B and α-C around each other by about 7°
in the metal-bound form (Fig. 5c). In consequence,
His313 at the N-terminus of helix α-B relocates more
than 8 Å toward the metal binding center (Fig. 5d).
Coordination of copper requires the proper
orientation of the four coordinating histidine sidend metal-free APP-E2 structures. (a) Superposition of the
P695 numbering) and metal-free APP-E2 (Arg441–Leu546,
the metal binding center in the structure, the histidine side
and the central copper ion is represented as a cyan sphere.
otation of helix α-B and the N-terminal half of helix α-C by
B in the copper-bound state of the APP-E2 domain requires
the copper and zinc binding site M1 of the APP-E2 domain
he color scheme is as in (a).
Fig. 6. Stabilization of metal-specific conformations of
the E2 domain in solution. (a) Limited proteolysis
experiments with trypsin. Protease cleavage products
are marked by arrowheads, and cleavage sites are listed
in Table 4. Note the double band 3/4 as also evidenced
by our sequencing data. Addition of copper to the
protein increases the stability of the N-terminal segment
(fragment 1), whereas zinc ions abrogate cleavage at
Arg385 and result in the accumulation of fragment 3.
(b) The N-terminus of the E2 domain is shown in
detail according to the B-factors of the cadmium-bound
structure. The side chains shown in sphere representation
(dark gray) mark the trypsin cleavage sites in the structure.
(c–e) Close-up of the region encompassing metal binding
site M1 (c) in the metal-free form14, (d) in the copper- and
(e) in the zinc-bound states. (f) A typical α-helical CD
spectrum of the APP-E2 domain with a characteristic
minimum at 222 nm (insert). Addition of metals (broken
lines) to APP-E2 (respective controls represented by
continuous lines) results in tighter folding of APP-E2 at
high temperatures, indicated by CD melting curves.
446 Conformation and Function of the APP-E2 Domainchains (His313, His382, His432 and His436). In
contrast, no specific orientation of the N-terminal
helix should be required in the zinc-bound state as a
water molecule replaces His313 as ligand. Conse-
quently, the available structural data imply at least
three different conformational states of the APP-E2
domain, differing in the flexibility of the N-terminal
coiled-coil: In the metal-free protein, helix α-B and
the N-terminal part of helix α-C are highly flexible. If
zinc is bound, the central helix α-C is stabilized as
His382 participates in metal coordination, but
movement of the amino acids located N-terminal
of His382 is still possible. However, binding of
copper requires concerted structural rearrange-
ments to establish the required coordination sphere,
and hence, movement of the coiled-coil helices is
restricted.
Binding of copper/zinc stabilizes metal-dependent
conformations of the APP-E2 domain in solution
In the crystals, we probably “trapped” one
conformation of the E2 domain. For this reason,
movement of the N-terminal helix is restricted by
the crystal packing, even if the binding site M1
becomes occupied by Zn2+. In order to verify the
expected metal-specific conformational states in
solution, we performed limited proteolysis and
circular dichroism (CD) spectroscopy experiments.
Previously, a stable fragment was identified in
limited proteolysis experiments with trypsin, com-
prising the amino acids Val385–Arg501 of APP695
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next to the recently mapped cleavage site of
meprin β.27 Interestingly, the N-terminal boundary
exactly matches the hinge region identified in the E2
domain (see above). The stable fragment hence lacks
a major part of the central helix α-C and helix α-B,
including the metal-coordinating residues His382
and His313. As binding of Cu2+ and Zn2+ is expected
to specifically affect the flexibility of helices α-C and
α-B and consequently the susceptibility to trypsin
cleavage, we performed limited proteolysis of the
E2 domain in the presence of these ions (Fig. 6a).
The N-termini of the resulting peptide fragments
were determined by Edman sequencing (Table 4).
The major trypsin cleavage products in the absence
of any metal ions indeed indicated rapid degrada-
tion of helices α-C and α-B N-terminal of Lys354
(fragment 2), Arg375 (fragment 3) and Arg385
(fragment 4). In contrast, the remaining C-terminal
fragment 4 starting at Val386 remains stable for
more than 1 h in the presence of trypsin once the
N-terminal coiled-coil region is cleaved off. This
observation is in agreement with the elevated
B-factors and hence flexibility of the amino acids
N-terminal of Ala355 (Fig. 6b).
Addition of copper to the proteolysis reaction
stabilizes especially fragment 1, corresponding to
the full-length protein, and to a lesser extent also
Table 4. Fragments generated by limited trypsin digestion
Fragmenta
N-terminal
sequence
Cleavage
site
Influence on
cleavage site
1b STPDc
2 AVIQ (K354)↓A355d Cu2+
3 QQLV (R375)↓Q376d Cu2+
4 VEAM (R385)↓V386d Zn2+; Cu2+
5 STPDc
a Numbers according to Fig. 6.
b Full-length protein after removal of a few C-terminal linker
residues that were left behind after V8 cleavage but do not belong
to the native APP sequence.
c The sequence STPD corresponds to the veryN-terminus of the
construct.
d In parentheses: S1 residue, C-terminally cleaved by trypsin.
447Conformation and Function of the APP-E2 Domainfragments 2 and 3 (Fig. 6a). This observation is in
excellent agreement with the structural properties of
the copper-bound E2 domain: Coordination of
copper requires a specific orientation of His313,
His382, His432 and His436 and hence a proper
orientation of helices α-B, α-C and α-D. Vice versa,
helices α-B, α-C and α-D are cross connected, and
their movement is necessarily restricted upon
copper binding, reducing the overall flexibility
and preventing the protein from proteolytic attack
(Fig. 6c and d). Once the N-terminal helix is cleaved
off by the protease, only three histidine side chains
are left for copper coordination, which is expected
to weaken the binding significantly. Accordingly,
the stabilizing effect of copper is expected to be
weaker for the smaller fragments 2 and 3 compared
to fragment 1 as seen in Fig. 6a.
Due to the different coordination sphere seen for
APP-E2-bound Zn2+, not involving His313 of helix
α-B, we expected a different effect of this ion on
APP-E2 stability. Indeed, if Zn2+ was present in the
cleavage reactions, a very strong site-specific pro-
tection was observed. Trypsin cleavage at Arg385
completely disappeared, and fragment 3 accumulated
(Fig. 6a). The abundance of the N-terminal fragment 5
also increased. Apparently, zinc specifically stabilizes
the region betweenArg375 andArg385 including the
coordinating His382. It does, however, still allow
flexibility in the region N-terminal of Arg375 as
His313 at the N-terminus of helix α-B does not
contribute to Zn2+ binding (Fig. 6e).
In agreement with the limited proteolysis data, we
observed a metal-dependent melting behavior of the
APP-E2 domain by CD spectroscopy (Fig. 6f).
Addition of copper and zinc results in an increased
CD signal at 222 nm and hence increased α-helical
content of the protein at high temperatures. The zinc-
bound E2 domain unfolds continuously in between
50 °C and 70 °C, and the melting temperature
increased from 57.8±0.3 °C to 64.2±0.3 °C upon
addition of 10 μM Zn2+. Copper binding to the E2
domain is accompanied by a largely altered unfold-
ing behavior of the protein. In addition to theelevated melting temperature (57.3±0.3 °C in plain
buffer versus 61.0±0.0 °C after addition of 10 μM
Cu2+), an increased unfolding cooperativity is
observed in the presence of copper. The protein
collapses at temperatures above 61 °C, indicated by
an increased slope of the melting curve. Our
structural data give a good explanation for this
cooperative collapse: The N-terminal coiled-coil is
characterized by increased flexibility and is conse-
quently expected to be more sensitive to heat-
induced unfolding than the C-terminal helix
bundle. Copper binding stabilizes the protein in
general, but destabilization or even partial unfold-
ing of the N-terminus at elevated temperatures will
weaken the coordination of Cu2+ by His313. Once
this bond breaks, the affinity to copper decreases
drastically, resulting in higher flexibility and rapid
unfolding of helix α-B, which in turn triggers
unfolding of the entire E2 domain. In contrast,
zinc binding causes a local stabilization of helix α-C
and the C-terminal core structure. It still allows
flexibility of the N-terminal coiled-coil region and
does not result in increased cooperativity during
unfolding.Discussion
We have identified a novel crystallization condi-
tion of the APP-E2 domain and refined its structure
to a resolution of 2.0 Å. Compared to previous
attempts to crystallize the highly flexible E2 domain,
the co-crystallization of the protein with metal ions
resulted in strikingly improved diffraction quality of
the crystals and lower overall B-factors. The
structure of the E2 domain revealed an intramolec-
ular metal binding site with high specificity and
affinity for zinc and copper.
Four highly conserved histidine side chains at
metal binding site M1 selectively provide a coordi-
nation geometry that fits to the first-row transition
metals copper and zinc. In contrast, the larger
cadmium ion is unspecifically bound in multiple
states. Coordination of zinc is facilitated by three
histidine residues and a water molecule, replacing
the side chain of His313 as fourth ligand. The pH-
dependent zinc binding properties of full-length
APP23 are in excellent agreement with a histidine-
mediated coordination. Four histidine side chains of
the E2 domain contribute to copper coordination at
this site, including His313. This observation is in
excellent agreement with the general coordination
properties of copper ions in biological macromole-
cules, preferring nitrogen to oxygen ligands.28
The functional importance of the metal binding
site of the APP-E2 domain is evident from the large
conformational changes in the protein confirmed by
SPR, the increased thermostability and the altered
protease accessibility upon binding of copper and
448 Conformation and Function of the APP-E2 Domainzinc. The metal-free but not the metal-bound state of
the E2 domain allows bending of the central
elongated helix and reorientation of the N-terminal
coiled-coil region. A comparable effect of metal
binding was, for example, described for human
endostatin,29 requiring coordination of zinc by the
otherwise flexible N-terminal region for its biolog-
ical activity. Binding of copper and zinc to APP-E2
does not only prevent structural flexibility but also
stabilize distinct conformations that depend on the
exact coordination sphere. Copper binding by the
E2 domain requires cooperative action of four
sequentially distant histidine side chains stabilizing
the overall structure. In contrast, the zinc-bound
state affects particularly the central helix and the
C-terminal helix bundle. These characteristics resem-
ble a metal-ion-triggered conformational switch that
converts the protein into different functional states,
in principle similar to metal-dependent regulatory
proteins such as calmodulin.30 In contrast to the
binary on/off switch of calmodulin, the competitive
metal binding properties of the E2 domain implicate
regulation in an even more complex manner,
employing multiple functional states.
The central question arising is: Is the described
competitive binding of Zn2+ and Cu2+ as well as the
resulting conformational changes of physiological
relevance? Membrane-bound and soluble APP are
transported to and localized at synaptic terminals
(e.g., Refs. 31–33). Maximum concentrations of more
than 10 μM zinc34 and/or copper4 are reached
during neuronal activity in hippocampal glutama-
tergic synapses, whereas basal levels of ∼20 nM free
zinc and ∼50 nM free copper were measured in the
brain interstitium35 and in the cerebrospinal fluid,36
respectively. We estimated a dissociation constant of
the E2–zinc complex of lower than 4 μM, in the same
order of magnitude as previously reported for full-
length APP (0.75 μM),23 indicating a significant
affinity for zinc within its physiological environ-
ment. Interestingly, Cu2+ binds tighter to APP-E2,
again in excellent agreement with the biochemical
properties of full-length APP (10 nM).22 Already an
underestimated correction for the competition with
the buffer compound results in an absolute Kd of
lower than 13 nM. Correspondingly, copper dis-
places zinc from the protein, a competition also
verified in respective ITC experiments. In conse-
quence, the E2 domain of APP sensitively responds
to elevated copper levels even in the presence of zinc.
Sequence alignments reveal a high degree of conser-
vation of this metal binding site among APP family
proteins, including APLP1 and APLP2. This indicates
its essential function also in APP-like proteins, which
most likely follow a similar antagonistic copper- and
zinc-dependent regulation scheme reflecting the
functional redundancy described for the APP family
members.37 Consequently, misregulation of the E2
domain based on imbalanced levels of copper andzinc is expected to impair the proper function of APP
and APP-like proteins. Interestingly, the metal
binding site of the E2 domain offers an explanation
for a number of previously unrelated findings in
molecular detail.
A ferroxidase-like activity of the E2 domain is
inhibited by zinc at micromolar concentrations but
not by copper.38 Based on our results, one might
expect the activation of the oxidase activity of the E2
domain by copper at low concentrations of inhibi-
tory zinc ions. This potential mechanism provides an
elegant explanation of how APP could be activated
to facilitate export of redox-active metal ions. Indeed,
several studies showed that the neuroprotective
α-secretase cleavage product sAPPα is involved in
oxidative stress response.39–41
The protein ligands F-Spondin42,43 and SorLA44
can bind to the E2 domain and regulate the neuronal
trafficking of APP. Strikingly, the interaction of E2
with these binding partners is inhibited in the
presence of the strong metal chelator ethylene
glycole tetraacetic acid.42,44 The localization of
APP is crucial for processing by regulated intra-
membrane proteolysis and hence for the produc-
tion of Aβ.3 Addition of copper to cells also affects
the trafficking of APP to the cell surface45 and
reduces amyloidogenic processing.46 Here we
propose a mechanism connecting ligand- and
metal-dependent regulation of APP: Metal binding
specifically switches the conformation of the E2
domain, which in turn should modulate the
interaction with its ligands and finally the traffick-
ing of APP. This regulation scheme is also
applicable to the E2 domains of APLP1 and
APLP2. Both proteins contain the metal binding
residues and are capable of interacting with
F-Spondin.42 Dysregulation of the neuronal metal
homeostasis in AD should therefore interfere with
the regulation of all APP family proteins. Malfunc-
tion of APP, APLP1 and APLP2 may therefore
directly contribute to the pathology in AD.
Our excellent diffracting crystals enable a struc-
ture-guided approach to develop small molecules
specifically influencing the metal-dependent confor-
mations of the E2 domain. Such compounds are
useful to investigate the conformation-dependent
regulation of the E2 domain. Furthermore, they
might prove useful to influence the cellular fate and
function of APP and to modulate the pathological
events leading to AD in future studies.Materials and Methods
Expression and purification
APP-E2 comprising Ser295–Asp500 (numbering accord-
ing to APP695) was recombinantly expressed in Escherichia
coli BL21(DE3)pRIL and purified by immobilized metal
449Conformation and Function of the APP-E2 Domainion chromatography as well as by gel permeation chroma-
tography as described previously.19 For crystallographic
and biochemical studies, the C-terminal hexa-histidine tag
was cleaved with either 20 U/mg protein coagulation factor
Xa (Novagen) for 24 h at 20 °C or 1.5 μg/mg protein–V8
protease (Calbiochem) for 1 h at 25 °C, respectively.
Protease and uncleaved protein were removed by applica-
tion to either a Benzamidine Sepharose 4 FF column (GE
Healthcare) combined with a HisTrap FF Crude column
(GE Healthcare) in the case of factor Xa or a HisTrap FF
Crude column combined with a HiTrap Heparin HP
column (GE Healthcare) in the case of V8 protease.
Crystallization and structure determination
Diffraction-quality crystals were grown by the sitting-
drop vapor diffusion method at 20 °C, mixing equal
volumes of 10 mg/ml protein solution and reservoir
containing 0.1 mM Hepes (pH 6.4), 1 M sodium acetate,
10 mM MgCl2 and 50 mM CdSO4; 12.5% R(−)-2-methyl-
2,4-pentanediol was added for cryoprotection. In compet-
itive metal binding experiments, crystals were soaked in
reservoir solution complemented with 10 mM CuCl2 or
ZnCl2 in addition to 40 mM CdSO4 for 12 h, including
the cryoprotectant. For analysis of Cu2+ and Zn2+ binding,
X-ray fluorescence scans were performed, and complete
anomalous data sets were collected at either end of the
respective K-absorption edges. Data sets were collected
at 100 K at the synchrotron (BESSY II/BL14.1 and
BL14.2/Berlin) and processed with programs of the CCP4
suite47 (Table 1). A high-resolution data set extending up
to 2.0 Å and a highly redundant SAD data set extending
to 2.7 Å at low energy were measured using cadmium-
containing crystals. Initial attempts to solve the phase
problem by MR using the available structure of human
APP-E2 (PDB ID: 1RW614) failed, implicating major
conformational differences. Finally, the phase problem was
solved by a combination ofMR and SAD. The PDB structure
3K66 (APL 120) was modified with CHAINSAW,48 and MR
was calculated in Phaser.49 Applying these phases to the
cadmium SAD low-energy data set, we identified seven
cadmium sites in the respective anomalous difference
Fourier map, followed by SAD phasing and density
modification in SHARP.50 The initial model, build in
Buccaneer,51 was transferred to the 2.0 Å-resolved
cadmium data set as well as to the copper and zinc peak
data sets, manually revised in MAIN52 and refined in CNS
v1.353 (for details, see Table 1). The occupancies of the
metal ions were refined by individual occupancy refine-
ment in CNS v1.3.53 All main-chain angles fall into the
most favored and additionally allowed regions of the
Ramachandran plot.54 Bond length, dihedral angles and
bond angles of His313, His382, His432 and His436 to Cd2+,
Zn2+ and Cu2+ were restrained to corresponding average
values derived from the Cambridge Structural Database.55
Composite annealed omit maps were calculated in CNS
v1.3 omitting 2.5% of the final model. Element-specific
“difference DANO maps” were calculated according to
Ref. 25. PyMOL (DeLano Scientific LLC, USA†) was used
for molecular graphics and the sequence-based structure
alignments.†www.pymol.orgContact analysis of the N-terminal coiled-coil
The interaction interface per protomer and the solvation
free-energy gain upon interface formation corresponding
to the hydrophobic interactions ΔiG were calculated with
PISA56 (Table 2). The following structures were used for
comparison: copper-bound APP-E2 (this work), metal-
free APP-E2 (PDB ID: 1RW614) and metal-free APL-1-E2
(PDB ID: 3K6620).Sequence alignment and analysis of APP-E2
conservation
Sequences of APP, APLP1 and APLP2 were aligned
using MUSCLE57 and manually edited to match the
structural superposition of human copper-bound APP-E2
and C. elegans APL-1. The following sequences were
obtained from the UniProt (UP) database58 or GENEBANK
to calculate the sequence alignments:Homo sapiensAPP (UP
code: D3DSD1), Mus musculus APP (UP code: Q6GR78),
Gallus gallus APP (UP code: Q9DGJ8), Xenopus laevis APP
(UP code: Q98SG0), Danio rerio APPa (UP code: Q90W28),
Drosophila melanogaster APPL (UP code: P14599), C. elegans
APL-1 (GENEBANK code: AAC46470.1), H. sapiens APLP1
(UP code: P51693) andH. sapiensAPLP2 (UP code: Q06481).Metal retention assay
APP-E2 (50 μM; without His-tag) and 75 μM CuCl2 in
50 mM Tris/HCl (pH 7.3), 150 mM NaCl or 75 μM ZnCl2
in 20 mM Hepes/NaOH (pH 7.3) and 150 mM NaCl were
concentrated 8-fold by ultrafiltration at 20 °C (Vivaspin
500, 5000 kDa molecular weight cutoff PES membranes;
Sartorius Stedim Biotech). Samples without protein, or
containing 50 μM lysozyme instead of APP-E2, served as
controls. Metal ions in the retenate were quantified
spectrophotometrically.59 Each experiment was performed
in triplicate, and the average ratio of the final concentra-
tion relative to the starting concentration (cmetal/cmetal,0)
is given.Isothermal titration calorimetry
ITC was performed at the same conditions as the
metal retention assays in a NANO ITC calorimeter
(TA Instruments, USA) adding 0.4 mM CuCl2 in 6-μl
injections or 0.4 mM ZnCl2 in 11-μl injections to the cell
containing 40 μM protein. Blank enthalphies for titrations
of metals in buffer were subtracted from peak integrals.
Binding constants were calculated with the NanoAnalyze
program (TA Instruments) using a model for a single set
of identical binding sites (Cu2+) and two sets of
independent binding sites (Zn2+). All titrations were
performed in triplicate. The initially determined Kdapp
of the APP-E2–Cu complex had to be corrected for
competition with the copper ligand Tris and its
pH-dependent protonation.26 The corrected Kd was
calculated according to Kd = Kdapp

1 + cTris10pK1 Trisð Þ =
1 + 10−pHKa
 
−1 usingpK1(Tris)=3.82
60 andpKa(Tris)=8.1.
In the case of zinc binding, the enthalpic data were
fitted to a binding model representing two sets of
independent binding sites, accounting for 1 strong
‡www.rcsb.org
450 Conformation and Function of the APP-E2 Domainbinding site and 3.3 weak binding sites (4.3 total Zn2+
sites) per protein molecule. Since Kd2 is determined not
statistically significant in the fit, a Kd1 of 3.9 μM and a Kd2
of 2.6 mM have to be regarded as upper (weakest) limits
(Table 3). A possibly lower Kd2 necessarily results in a
decreased Kd1 value. Higher values of Kd2, however,
would affect Kd1 slightly but would cause an increase in
ΔH2 to values even higher than 1200 kJ/mol, unlikely for
non-covalent interactions.
ITC measurements at high Zn/protein ratios
The effect of excessive zinc-to-protein ratios was studied
in ITC experiments, where three repeating titrations were
performed in series into the same cell solution. Titrationwas
performed in 20 mM Hepes/NaOH (pH 7.3) and 150 mM
NaCl at 20 °C, adding a 0.8 mM ZnCl2 solution in 3×22
injections to 40μMAPP-E2, resulting in a final Zn2+/protein
ratio of 22. The molar ratios for titration experiments 2 and
3 were calculated neglecting intermixture of cell volume
and slight volume changes occurring after refill of the
syringe. Blank heats for titrations of metals in buffer were
subtracted from peak integrals.
Determination of total Zn2+ binding sites on APP-E2
The protein was saturated with 10 mM ZnCl2 in 20 mM
Hepes/NaOH (pH 7.3) and 150 mM NaCl, resulting in
quantitative precipitation of the protein. The precipitate
was washed with buffer until a stable equilibrium ratio of
zinc-saturated protein in the liquid phase and the solid
phase was reached. The concentrations of Zn2+59 and
protein61 were determined after each wash step in the
liquid phase (supernatant) after 5 min of centrifugation at
16,000g. The ratio between [Zn2+] and [APP-E2] under
equilibrium conditions corresponds to the total number of
zinc binding sites per protein molecule, which was
determined to be 4.3±0.2 (Fig. 3f). Subtraction of the one
strong binding site yields the number additional weak
binding sites as 3.3.
SPR analysis
SPR analysis was performed using a BIAcore 3000 setup
(GE Healthcare) with an SCB CMD500L sensor chip
(Xantec). APP-E2 was coupled to the sensor chip surface
via an amine coupling protocol according to the manufac-
turer's instructions in amounts that yielded 6000 RU. Metal
binding analysis was performed at 25 °C in 10 mM Hepes,
135 mM NaCl, 6 mM KCl and 5.5 mM glucose at pH 7.1.
For metal chelation experiments, 20 mM citrate (Zn) and
20 mM Tris (Cu) at pH 6.8, respectively, were added and
injected with a flow rate of 30 μl/min followed by a
dissociation phase of 7 min. The chip was rinsed by sequent
injections of running buffer containing 3 mM ethylenedia-
minetetraacetic acid and 10 mMHCl. Spectra were baseline
corrected against an unloaded flow cell and set to zero.
Limited proteolysis
Limited proteolysis was performed in 20 mM Hepes
and 150 mM NaCl at pH 7.4 containing 0.5 μg/ml trypsin(Calbiochem) and 20 μM purified protein (α-casein as
control). Copper or zinc was supplemented at 40 μM to the
samples. Reactions were stopped after 30 and 60 min by
addition of 10 mM PMSF and analyzed by SDS-PAGE.
Protease cleavage sites were characterized by Edman
sequencing (Procise 494A; Applied Biosystems, Foster
City, CA, USA). Limited proteolysis experiments were
reproduced in three independent experiments.
CD spectroscopy
CD data were collected on a J-710 spectropolarimeter
(Jasco Corporation) employing the ITC-buffers adding
7.5 μMAPP-E2 and 10 μMzinc or copper. CD signals were
measured at 222 nm upon heating (1 °C/min) of the
samples from 20 °C to 90 °C. The blank signals produced
by the buffers at 20 °C were subtracted as constant values
from the melting curves. Melting points correspond to the
maximum of the first-order derivative of the melting
curves calculated with spectra analysis software (Jasco
Corporation).
Accession codes
Data deposition: The atomic coordinates and structure
factors have been deposited in the PDB‡ (PDB IDs: 3UMH,
3UMI and 3UMK).Acknowledgements
The authors thank J. Roy for the help during
crystallization and C. Breithaupt for critical reading
of the manuscript. We acknowledge the Helmholtz
Zentrum Berlin BESSY II for provision of synchro-
tron radiation at beamlines BL 14.1 and BL 14.2 and
thank the scientific staff for assistance. This work was
supported by the Deutsche Forschungsgemeinschaft
(MU901), the International Copper Association (to
G.M.) and the Breuer Stiftung (to G.M.).Supplementary Data
Supplementary data associated with this article
can be found, in the online version, at doi:10.1016/
j.jmb.2011.12.057References
1. Blennow, K., de Leon, M. J. & Zetterberg, H. (2006).
Alzheimer's disease. Lancet, 368, 387–403.
2. Haass, C. & Selkoe, D. J. (2007). Soluble protein
oligomers in neurodegeneration: lessons from the
451Conformation and Function of the APP-E2 DomainAlzheimer's amyloid beta-peptide. Nat. Rev., Mol. Cell
Biol. 8, 101–112.
3. Lichtenthaler, S. F., Haass, C. & Steiner, H. (2011).
Regulated intramembrane proteolysis—lessons from
amyloid precursor protein processing. J. Neurochem.
117, 779–796
4. Hung, Y. H., Bush, A. I. & Cherny, R. A. (2010).
Copper in the brain and Alzheimer's disease. J. Biol.
Inorg. Chem. 15, 61–76.
5. Watt, N. T., Whitehouse, I. J. & Hooper, N. M. (2010).
The role of zinc in Alzheimer's disease. Int. J.
Alzheimers Dis. 2011, 971021.
6. Bayer, T. A. & Multhaup, G. (2006). The role of metal
ions in the amyloid precursor protein and in Alzhei-
mer's disease. In Neurodegenerative Diseases and Metal
Ions (Sigel, A., Sigel, H. & Sigel, R. K. O., eds), Vol. 1,
John Wiley & Sons, Ltd, Chichester, UK.
7. Jacobsen, K. T. & Iverfeldt, K. (2009). Amyloid
precursor protein and its homologues: a family of
proteolysis-dependent receptors. Cell. Mol. Life Sci. 66,
2299–2318.
8. Dahms, S. O., Hoefgen, S., Roeser, D., Schlott, B.,
Guhrs, K. H. & Than, M. E. (2010). Structure and
biochemical analysis of the heparin-induced E1 dimer
of the amyloid precursor protein. Proc. Natl Acad. Sci.
USA, 107, 5381–5386.
9. Reinhard, C., Hebert, S. S. & De Strooper, B.
(2005). The amyloid-beta precursor protein: inte-
grating structure with biological function. EMBO J.
24, 3996–4006.
10. Soba, P., Eggert, S., Wagner, K., Zentgraf, H., Siehl, K.,
Kreger, S. et al. (2005). Homo- and heterodimerization
of APP family members promotes intercellular adhe-
sion. EMBO J. 24, 3624–3634.
11. Kaden, D., Munter, L. M., Joshi, M., Treiber, C., Weise,
C., Bethge, T. et al. (2008). Homophilic interactions of
the amyloid precursor protein (APP) ectodomain are
regulated by the loop region and affect beta-secretase
cleavage of APP. J. Biol. Chem. 283, 7271–7279.
12. Scheuermann, S., Hambsch, B., Hesse, L., Stumm, J.,
Schmidt, C., Beher, D. et al. (2001). Homodimerization
of amyloid precursor protein and its implication in the
amyloidogenic pathway of Alzheimer's disease. J. Biol.
Chem. 276, 33923–33929.
13. Gralle, M., Oliveira, C. L., Guerreiro, L. H., McKinstry,
W. J., Galatis, D., Masters, C. L. et al. (2006). Solution
conformation and heparin-induced dimerization of
the full-length extracellular domain of the human
amyloid precursor protein. J. Mol. Biol. 357, 493–508.
14. Wang, Y. & Ha, Y. (2004). The X-ray structure of an
antiparallel dimer of the human amyloid precursor
protein E2 domain. Mol. Cell, 15, 343–353.
15. Kaden, D., Voigt, P., Munter, L. M., Bobowski, K. D.,
Schaefer, M. & Multhaup, G. (2009). Subcellular
localization and dimerization of APLP1 are strikingly
different from APP and APLP2. J. Cell Sci. 122,
368–377.
16. Lee, S., Xue, Y., Hu, J., Wang, Y., Liu, X., Demeler, B. &
Ha, Y. (2011). The E2 domains of APP and APLP1
share a conserved mode of dimerization. Biochemistry,
50, 5453–5464.
17. Baumkotter, F., Wagner, K., Eggert, S., Wild, K. &
Kins, S. (2011). Structural aspects and physiological
consequences of APP/APLP trans-dimerization. Exp.Brain Res. Sep 28. [Epub ahead of print], doi:10.1007/
s00221-011-2878-6.
18. Xue, Y., Lee, S. & Ha, Y. (2011). Crystal structure of
amyloid precursor-like protein 1 and heparin complex
suggests a dual role of heparin in E2 dimerization.
Proc. Natl Acad. Sci. USA, 108, 16229–16234.
19. Keil, C., Huber, R., Bode, W. & Than, M. E. (2004).
Cloning, expression, crystallization and initial crys-
tallographic analysis of the C-terminal domain of the
amyloid precursor protein APP. Acta Crystallogr., Sect.
D: Biol. Crystallogr. 60, 1614–1617.
20. Hoopes, J. T., Liu, X., Xu, X., Demeler, B., Folta-
Stogniew, E., Li, C. & Ha, Y. (2010). Structural
characterization of the E2 domain of APL-1, a
Caenorhabditis elegans homolog of human amyloid
precursor protein, and its heparin binding site. J. Biol.
Chem. 285, 2165–2173.
21. Dulubova, I., Ho, A., Huryeva, I., Sudhof, T. C. &
Rizo, J. (2004). Three-dimensional structure of an
independently folded extracellular domain of human
amyloid-beta precursor protein. Biochemistry, 43,
9583–9588.
22. Hesse, L., Beher, D., Masters, C. L. & Multhaup, G.
(1994). The beta A4 amyloid precursor protein
binding to copper. FEBS Lett. 349, 109–116.
23. Bush, A. I., Multhaup, G., Moir, R. D., Williamson,
T. G., Small, D. H., Rumble, B. et al. (1993). A
novel zinc(II) binding site modulates the function
of the beta A4 amyloid protein precursor of
Alzheimer's disease. J. Biol. Chem. 268, 16109–16112.
24. Kong, G. K., Adams, J. J., Harris, H. H., Boas, J. F.,
Curtain, C. C., Galatis, D. et al. (2007). Structural
studies of the Alzheimer's amyloid precursor protein
copper-binding domain reveal how it binds copper
ions. J. Mol. Biol. 367, 148–161.
25. Than, M. E., Henrich, S., Bourenkov, G. P., Bartunik,
H. D., Huber, R. & Bode, W. (2005). The endoprotei-
nase furin contains two essential Ca2+ ions stabilizing
its N-terminus and the unique S1 specificity pocket.
Acta Crystallogr., Sect. D: Biol. Crystallogr. 61, 505–512.
26. Hatcher, L. Q., Hong, L., Bush, W. D., Carducci, T. &
Simon, J. D. (2008). Quantification of the binding
constant of copper(II) to the amyloid-beta peptide.
J. Phys. Chem. B, 112, 8160–8164.
27. Jefferson, T., Causevic, M., auf dem Keller, U.,
Schilling, O., Isbert, S., Geyer, R. et al. (2011).
Metalloprotease meprin beta generates nontoxic
N-terminal amyloid precursor protein fragments
in vivo. J. Biol. Chem. 286, 27741–27750.
28. Harding, M. M. (2004). The architecture of metal
coordination groups in proteins.Acta Crystallogr., Sect.
D: Biol. Crystallogr. 60, 849–859.
29. Han, Q., Fu, Y., Zhou, H., He, Y. & Luo, Y. (2007).
Contributions of Zn(II)-binding to the structural
stability of endostatin. FEBS Lett. 581, 3027–3032.
30. Gifford, J. L., Walsh, M. P. & Vogel, H. J.
(2007). Structures and metal-ion-binding properties
of the Ca2+-binding helix–loop–helix EF-hand motifs.
Biochem. J. 405, 199–221.
31. Schubert, W., Prior, R., Weidemann, A., Dircksen, H.,
Multhaup, G., Masters, C. L. & Beyreuther, K. (1991).
Localization of Alzheimer beta A4 amyloid precursor
protein at central and peripheral synaptic sites. Brain
Res. 563, 184–194.
452 Conformation and Function of the APP-E2 Domain32. Sabo, S. L., Ikin, A. F., Buxbaum, J. D. & Greengard, P.
(2003). The amyloid precursor protein and its regula-
tory protein, FE65, in growth cones and synapses in
vitro and in vivo. J. Neurosci. 23, 5407–5415.
33. Groemer, T. W., Thiel, C. S., Holt, M., Riedel, D., Hua,
Y., Huve, J. et al. (2011). Amyloid precursor protein is
trafficked and secreted via synaptic vesicles. PLoS One,
6, e18754.
34. Paoletti, P., Vergnano, A. M., Barbour, B. & Casado, M.
(2009). Zinc at glutamatergic synapses. Neuroscience,
158, 126–136.
35. Frederickson, C. J., Giblin, L. J., 3rd, Balaji, R. V.,
Masalha, R., Frederickson, C. J., Zeng, Y. et al. (2006).
Synaptic release of zinc from brain slices: factors
governing release, imaging, and accurate calculation
of concentration. J. Neurosci. Methods, 154, 19–29.
36. Boll, M. C., Alcaraz-Zubeldia, M., Montes, S. & Rios,
C. (2008). Free copper, ferroxidase and SOD1 activi-
ties, lipid peroxidation and NO(x) content in the CSF.
A different marker profile in four neurodegenerative
diseases. Neurochem. Res. 33, 1717–1723.
37. Anliker, B. & Muller, U. (2006). The functions of
mammalian amyloid precursor protein and related
amyloid precursor-like proteins. Neurodegener. Dis. 3,
239–246.
38. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A.,
Robb, E., Wikhe, K. et al. (2010). Iron-export ferroxidase
activity of beta-amyloid precursor protein is inhibited
by zinc in Alzheimer's disease. Cell, 142, 857–867.
39. Goodman, Y. & Mattson, M. P. (1994). Secreted forms
of beta-amyloid precursor protein protect hippocam-
pal neurons against amyloid beta-peptide-induced
oxidative injury. Exp. Neurol. 128, 1–12.
40. Clement, A. B., Gimpl, G. & Behl, C. (2010). Oxidative
stress resistance in hippocampal cells is associated with
altered membrane fluidity and enhanced nonamyloi-
dogenic cleavage of endogenous amyloid precursor
protein. Free Radical Biol. Med. 48, 1236–1241.
41. Lezoualc'h, F., Engert, S., Berning, B. & Behl, C. (2000).
Corticotropin-releasing hormone-mediated neuropro-
tection against oxidative stress is associated with the
increased release of non-amyloidogenic amyloid beta
precursor protein and with the suppression of nuclear
factor-kappaB. Mol. Endocrinol. 14, 147–159.
42. Ho, A. & Sudhof, T. C. (2004). Binding of F-spondin to
amyloid-beta precursor protein: a candidate amyloid-
beta precursor protein ligand that modulates amy-
loid-beta precursor protein cleavage. Proc. Natl Acad.
Sci. USA, 101, 2548–2553.
43. Hoe, H. S., Wessner, D., Beffert, U., Becker, A. G.,
Matsuoka, Y. & Rebeck, G. W. (2005). F-spondin
interaction with the apolipoprotein E receptor ApoEr2
affects processing of amyloid precursor protein. Mol.
Cell Biol. 25, 9259–9268.
44. Andersen, O. M., Schmidt, V., Spoelgen, R., Gliemann,
J., Behlke, J., Galatis, D. et al. (2006). Molecular
dissection of the interaction between amyloid precur-
sor protein and its neuronal trafficking receptor
SorLA/LR11. Biochemistry, 45, 2618–2628.
45. Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q. X.,
Laughton, K., Wikhe, K. et al. (2011). Copper promotesthe trafficking of the amyloid precursor protein. J. Biol.
Chem. 286, 8252–8262.
46. Hung, Y. H., Robb, E. L., Volitakis, I., Ho, M.,
Evin, G., Li, Q. X. et al. (2009). Paradoxical conden-
sation of copper with elevated beta-amyloid in lipid
rafts under cellular copper deficiency conditions:
implications for Alzheimer disease. J. Biol. Chem.
284, 21899–21907.
47. Collaborative Computational Project. (1994). The
CCP4 suite: programs for protein crystallography.
Acta Crystallogr., Sect. D: Biol. Crystallogr. 50, 760–763.
48. Stein, N. (2008). CHAINSAW: a program for mutating
pdb files used as templates in molecular replacement.
J. Appl. Crystallogr. 41, 641–643.
49. McCoy, A. J., Grosse-Kunstleve, R. W., Adams,
P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007).
Phaser crystallographic software. J. Appl. Crystallogr.
40, 658–674.
50. de La Fortelle, E. & Bricogne, G. (1997). Maximum-
likelihood heavy-atom parameter refinement for mul-
tiple isomorphous replacement and multiwavelength
anomalous diffractionmethods.Methods Enzymol. 276,
472–494.
51. Cowtan, K. (2006). The Buccaneer software for auto-
mated model building. 1. Tracing protein chains. Acta
Crystallogr., Sect. D: Biol. Crystallogr. 62, 1002–1011.
52. Turk, D. (1992). Weiterentwicklung eines Pro-
gramms für Molekülgraphik und Elektronendichte-
Manipulation und seine Anwendung auf verschiedene
Protein Strukturaufklärungen. PhD thesis (Technische
Universität München, Munich, Germany).
53. Brunger, A. T. (2007). Version 1.2 of the crystallogra-
phy and NMR system. Nat. Protoc. 2, 2728–2733.
54. Ramachandran, G. N. & Sasisekharan, V. (1968).
Conformation of polypeptides and proteins. Adv.
Protein Chem. 23, 283–438.
55. Allen, F. H. (2002). The Cambridge Structural
Database: a quarter of a million crystal structures
and rising. Acta Crystallogr., Sect. B: Struct. Sci. 58,
380–388.
56. Krissinel, E. & Henrick, K. (2007). Inference of
macromolecular assemblies from crystalline state.
J. Mol. Biol. 372, 774–797.
57. Edgar, R. C. (2004). MUSCLE: multiple sequence
alignment with high accuracy and high throughput.
Nucleic Acids Res. 32, 1792–1797.
58. UniProt (2011). Ongoing and future developments at
the Universal Protein Resource. Nucleic Acids Res. 39,
D214–D219.
59. Sabel, C. E., Neureuther, J. M. & Siemann, S. (2010). A
spectrophotometric method for the determination of
zinc, copper, and cobalt ions in metalloproteins using
Zincon. Anal. Biochem. 397, 218–226.
60. Canepari, S., Carunchio, V., Castellano, P. & Messina,
A. (1999). Complex formation equilibria of some beta-
amino-alcohols with lead(II) and cadmium(II) in
aqueous solution. Talanta, 47, 1077–1084.
61. Bradford, M. M. (1976). A rapid and sensitive method
for the quantitation of microgram quantities of protein
utilizing the principle of protein–dye binding. Anal.
Biochem. 72, 248–254.
